She received her Ph.D. in analytical chemistry from Purdue University under the mentorship of R. Graham Cooks, and pursued her postdoctoral research at Stanford University in the Richard N. Zare laboratory. Eberlin is passionate about research at the interface of chemistry and medicine. Her research group is focused on developing innovative mass spectrometry technologies to address critical problems in health-related research. In particular, the Eberlin lab applies refined mass spectrometry imaging and statistical tools to discover novel metabolic signatures of cancer with the goal of translating this technology to the clinic for rapid and accurate cancer diagnosis.